Royal Philips has revealed the augmented reality concept for image-guided minimally invasive therapies it developed with Microsoft.

Burnout among physicians improved slightly over the last few years, but not all specialties have seen much of a difference, according to data published in Mayo Clinic Proceedings.

A proposed merger between two major health insurance providers ended in a messy breakup after antitrust issues prohibited the roughly $50 billion transaction in 2017. Now, the two companies, Anthem and Cigna, are still disputing which company will foot the costs of the failed deal, Bloomberg Quint reported.

Two U.S. senators launched a bipartisan investigation into rising insulin prices on Feb. 22, sending letters to the drug's top three manufacturers seeking information about why costs have risen so sharply in recent years.

Patients with coronary artery disease (CAD) enrolled in private insurance plans through Medicare Advantage (MA) are more likely to receive guideline-recommended medications for secondary prevention than those in fee-for-service Medicare, according to a new analysis in JAMA Cardiology. But that wasn't tied to improvements in blood pressure or cholesterol levels.

CivicaRx, the not-for-profit entity created last year by a group of health systems and hospitals, is planning to achieve its goals of lowering drug prices and addressing shortages in hospitals by working directly with pharmaceutical companies and buying drugs, Bloomberg reported.

The Royal Australia and New Zealand College of Radiologists (RANZCR) recently unveiled a draft of ethical guidelines for the emerging use of machine learning and AI in medicine.

Some companies in particular are rising above the fray with their innovative solutions, according to Fast Company, which ranked the most innovative companies for 2019 across industries and overall.